Pneumococcal conjugate second or third-dose vaccines (PCVc) in Liberia
Liberia: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 80.0% in 2025. ◆ Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Liberia, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) in Liberia is 80.0%, measured in 2025. That is the highest value across all 18 years on record.
Compared with earlier readings it is up 122.2% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Liberia peaked at 80.0% in 2023 and was at its lowest, 0.0%, in 2008.
Liberia ranks 118th of 194 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Liberia, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 25.0% | — |
| 2015 | 36.0% | +44.0% |
| 2016 | 73.0% | +102.8% |
| 2017 | 78.0% | +6.8% |
| 2018 | 78.0% | +0.0% |
| 2019 | 68.0% | -12.8% |
| 2020 | 65.0% | -4.4% |
| 2021 | 65.0% | +0.0% |
| 2022 | 74.0% | +13.8% |
| 2023 | 80.0% | +8.1% |
| 2024 | 80.0% | +0.0% |
| 2025 | 80.0% | +0.0% |
Liberia compared with similar countries
- Liberia's 80.0% is above the median for low income countries, which is 80.0%, 1.0× the median. (25 countries reporting)
- Liberia's 80.0% is below the median for Sub-Saharan Africa, which is 82.5%, 97% of the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 35.8% | 0.0% | 78.0% | 10 |
| 2020s | 74.0% | 65.0% | 80.0% | 6 |
Countries ranked near Liberia
More health data for Liberia
- Un projection of annual infant deaths, annual growth rate -1.57 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7528 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,097 deaths per 1,000 people (2090)
- Number of infants who die before age 1 3,457 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 7 (2025)
- Population ages 00-04, female, annual growth rate 1.13 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.068 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.13 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Liberia?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Liberia was 80.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Liberia?
- The highest recorded value was 80.0% in 2023.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Liberia?
- The lowest recorded value was 0.0% in 2008.
- How does Liberia rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Liberia ranks 118th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Liberia?
- Over the last ten years it is up 122.2%. The long-run trend across the full record is volatile.
- Where does this Liberia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).